EarningsQ1 2025 Earnings Report

Recursion Pharmaceuticals (RXRX) Q1 2025 Earnings Report

7 Followers

MX:RXRX Q1 2025 EPS Results

Actual EPS-$9.08

Consensus EPS-$9.37

Beat/MissBeat by +$0.29

One Year Ago EPS-$7.08

Actual Revenue$267.79M

Expected Revenue$272.11M

Beat/MissMissed by -$4.32M

YoY Revenue Growth+6.89%

QuarterQ1 2025

Date05/05/2025

TimeBefore Open

Conference CallMonday, May 5, 2025

MX:RXRX Upcoming Earnings

Recursion Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:RXRX Q1 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-4.00 / -	-6.538	―
Aug 05, 2026	2026 (Q2)	-4.36 / -4.54	-7.446	39.02% (+2.91)
May 06, 2026	2026 (Q1)	-4.81 / -4.00	-9.081	56.00% (+5.09)
Feb 25, 2026	2025 (Q4)	-5.47 / -3.81	-9.626	60.38% (+5.81)
Nov 05, 2025	2025 (Q3)	-6.85 / -6.54	-6.175	-5.88% (-0.36)
Aug 05, 2025	2025 (Q2)	-6.41 / -7.45	-7.265	-2.50% (-0.18)
May 05, 2025	2025 (Q1)	-9.37 / -9.08	-7.083	-28.21% (-2.00)
Feb 28, 2025	2024 (Q4)	-7.46 / -9.63	-7.628	-26.19% (-2.00)
Nov 06, 2024	2024 (Q3)	-6.05 / -6.17	-7.809	20.93% (+1.63)
Aug 08, 2024	2024 (Q2)	-6.97 / -7.26	-6.901	-5.26% (-0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed